These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28414094)

  • 1. Effect of aging and Alzheimer's disease-like pathology on brain monoamines in mice.
    Von Linstow CU; Severino M; Metaxas A; Waider J; Babcock AA; Lesch KP; Gramsbergen JB; Finsen B
    Neurochem Int; 2017 Sep; 108():238-245. PubMed ID: 28414094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.
    von Linstow CU; Waider J; Grebing M; Metaxas A; Lesch KP; Finsen B
    Alzheimers Res Ther; 2017 Sep; 9(1):74. PubMed ID: 28899417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
    Thygesen C; Metaxas A; Larsen MR; Finsen B
    J Alzheimers Dis; 2018; 64(4):1247-1259. PubMed ID: 29991132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
    Xian-hui D; Wei-juan G; Tie-mei S; Hong-lin X; Jiang-tao B; Jing-yi Z; Xi-qing C
    J Trace Elem Med Biol; 2015 Apr; 30():118-23. PubMed ID: 25575693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical changes in a double transgenic mouse model of Alzheimer's disease fed a pro-oxidant diet.
    Ash ES; Alavijeh MS; Palmer AM; Mitchelmore C; Howlett DR; Francis PT; Broadstock M; Richardson JC
    Neurochem Int; 2010 Nov; 57(5):504-11. PubMed ID: 20600435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered brain arginine metabolism with age in the APP
    Vemula PK; Jing Y; Cicolini J; Zhang H; Mockett BG; Abraham WC; Liu P
    Neurochem Int; 2020 Nov; 140():104798. PubMed ID: 32711019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM; Hölscher C
    Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease.
    Bilousova T; Taylor K; Emirzian A; Gylys R; Frautschy SA; Cole GM; Teng E
    Neurobiol Dis; 2015 Feb; 74():32-40. PubMed ID: 25449907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
    Miettinen R; Riedel A; Kalesnykas G; Kettunen HP; Puoliväli J; Soininen H; Arendt T
    J Chem Neuroanat; 2005 Oct; 30(2-3):105-18. PubMed ID: 16081247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.
    Maheswaran S; Barjat H; Rueckert D; Bate ST; Howlett DR; Tilling L; Smart SC; Pohlmann A; Richardson JC; Hartkens T; Hill DL; Upton N; Hajnal JV; James MF
    Brain Res; 2009 May; 1270():19-32. PubMed ID: 19272356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice.
    Metaxas A; Vaitheeswaran R; Jensen KT; Thygesen C; Ilkjaer L; Darvesh S; Finsen B
    Curr Alzheimer Res; 2018 Mar; 15(5):420-428. PubMed ID: 28982335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-Dependent Increase of Chitinase1 in APP/PS1 Double Transgenic Mice.
    Xiao Q; Shi R; Yang W; Zou Y; Du Y; Zhang M; Yu W; Lü Y
    Neurochem Res; 2016 Jul; 41(7):1604-11. PubMed ID: 26935740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing effects of APP/PS1 and TrkB.T1 genotypes on midbrain dopamine neurons and stimulated dopamine release in vivo.
    Kärkkäinen E; Yavich L; Miettinen PO; Tanila H
    Brain Res; 2015 Oct; 1622():452-65. PubMed ID: 26168899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
    Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.